Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
143.45
-0.06 (-0.04%)
At close: Oct 29, 2026, 4:00 PM EDT
147.16
+3.71 (2.58%)
Pre-market: Oct 30, 2026, 7:25 AM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Axsome Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $277.86. The average 1-year stock price forecast is 93.70% higher than the current stock price, while the lowest is $238 (+65.91%) and the highest is $380 (+164.90%).
Price Target: $277.86 (+93.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 18 | 18 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 21 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $316 → $284 | Buy | Maintains | $316 → $284 | +97.98% | Oct 29, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $280 | Buy | Maintains | $280 | +95.19% | Oct 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $258 → $238 | Buy | Reiterates | $258 → $238 | +65.91% | Oct 26, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $280 → $256 | Buy | Maintains | $280 → $256 | +78.46% | Oct 15, 2026 |
| Needham | Needham | Buy Reiterates $268 | Buy | Reiterates | $268 | +86.82% | Oct 15, 2026 |
Financial Forecast
Revenue This Year
949.73M
from 638.50M
Increased by 48.74%
Revenue Next Year
1.51B
from 949.73M
Increased by 59.14%
EPS This Year
-2.98
from -3.47
EPS Next Year
3.69
from -2.98
EPS and Forward PE are based on non-GAAP adjusted numbers.